Ovarian Cancer and Us - best viewed in FIREFOX

Search: this blog, links from posts and the web.....

Loading...

Wednesday, February 17, 2010

short video - inclusionary Should science be more democratic?




video regarding Competition/Science Policy




Research programs & studies - Cancer Prevention Institute of California



Research programs & studies
Studies of ovarian cancer

* Comorbidity and treatment for ovarian cancer / Survival following ovarian cancer

* Diet and risk of ovarian cancer

* Follow-up Care Us by Survivors (FOCUS study)

* Genetic epidemiology of ovarian cancer

Home page - Cancer Prevention Institute of California



The Most Outrageous Examples Of Health Insurers Denying Coverage - Huffington Post



"We compiled a list of some of the worst cases of insurance companies denying sick customers access to medical care. Check them out below -- and if you've been denied coverage, click "Participate" and tell us your story."

Can Catumaxomab Keep Away Ovarian Cancer? Video



Note: and adorable baby puppies

obituary/author: Karen Buhler-Wilkerson (ovarian cancer) nursing professor



"Karen Buhler-Wilkerson, 65, of Center City, who retired in 2006 as a professor of community health at the University of Pennsylvania School of Nursing, died Saturday at the university hospital of complications from ovarian cancer. The author of three books, Dr. Buhler-Wilkerson wrote her last paper, "Living With Cancer," with her life partner of 17 years, Dr. Neville Strumpf, for publication this summer in the quarterly journal Nursing Clinics of North America."

No clear evidence for universal supplementation -- Vitamin D




Disrupted lives and threats to identity: The experiences of people with colorectal cancer within the first year following diagnosis -- Hubbard et al. 14 (2): 131 -- Health:



Note: It's very unfortunate that this is not full access as it would apply across cancer domains.

"We conclude that universal application of the concept biographical disruption to the experience of cancer within the first year of diagnosis is not appropriate. This study has implications for cancer services, in particular, the findings call for the development of interventions to support those people who experience cancer as an assault on their identity."

Beyond the black box: drug- and device-associated hypersensitivity events



ONCOPET cancer test for companion animals



Genome study shows what cancers have in common - news item



"The finding, based on a large-scale study of the genetic make-up of 26 different types of cancers, suggests cancer has less to do with where in the body it occurs, and more to do with the genetic changes that cause it to grow......What that means for treatment is that many treatments may be used across many different kinds of cancers."

Ovarian Cancer Pathogenesis: A Model in Evolution



Directory of open access journals



Directory of open access journals

full access: Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features



The cost-effectiveness of genetic testing strategies for Lynch Syndrome (U.S.)



Coherence and Completeness of Population-based Family Cancer Reports



Conclusions: These findings suggest that family history of cancer reports from the general population are generally complete and coherent.

Identification of Ovarian Cancer Symptoms in Health Insurance Claims Data



Conclusions:
"These results support previous findings that ovarian cancer symptoms were reported in health insurance claims and were more prevalent before diagnosis, but the symptoms may occur too close to the diagnosis date to provide useful diagnostic information. The passive screening approach should be reevaluated in the future using electronic medical records; if found to be effective, the method may be potentially useful for other incident diseases."

If only WHI was done well -- BMJ (Drug firm conflicting interests)



"Barrington claims that the women’s health initiative (WHI) trial had impeccable standards.1 We recently highlighted some of its shortcomings relating to hormone replacement therapy (HRT). The data and safety monitoring board used a global index of health which was modified on three occasions...."

Fluorescent probes light up cancerous tumors



In research:
"In a series of studies, working mainly in mice with implanted human tumors, the researchers showed that if tumors had spread to surrounding tissue, the ACCP-nanoparticle probes enabled them to visualize areas of tumors that they wouldn't ordinarily see -- either because the tissue was buried beneath other tissue or the tumor simply was difficult to distinguish from normal tissue."